HOME / Featured News / HIGHLIGHTED NEWS
Medicare Overpaid Billions in 2010, GAO Says
Rate This Article:
0

Medpagetoday.com REPORTS HERE that "the U.S. government overpaid private insurance companies administering Medicare Advantage plans by as much as $3.1 billion in 2010, according to a new report from the Government Accountability Office (GAO)."

"About a quarter of all Medicare beneficiaries are enrolled in Medicare Advantage plans, and the Centers for Medicare and Medicaid Services (CMS) paid about $114 billion to the plans in 2010."

"Democrats have criticized CMS for paying Medicare Advantage plans too much in comparison with traditional fee-for-service Medicare plans, and the Affordable Care Act cut payments to Medicare Advantage by more than $100 billion over 10 years."

"CMS determines how much it pays Medicare Advantage plans and traditional fee-for-service providers by calculating a risk score for each enrolled beneficiary. To calculate the score, CMS determines how much that individual's healthcare costs are expected to be relative to the entire Medicare fee-for-service population. CMS generally pays more money for beneficiaries in poor health than for those in good health."

"Risk scores should be the same for beneficiaries with the same health conditions, age, and other characteristics, GAO said. However, its investigation found that's not the case. CMS gets information on the medical diagnoses of fee-for-service patients by analyzing the claims that fee-for-service providers submit to CMS for payment. By contrast, CMS doesn't see medical claims for Medicare Advantage patients; rather it determines diagnoses of patients in those plans by relying on diagnosis codes submitted to CMS by the insurance plans."

"The claims submitted by the insurance companies often contain more codes than those analyzed by CMS from fee-for-service providers, making it appear that Medicare Advantage patients are sicker than they actually are; that results in Medicare Advantage plans being paid more for their beneficiaries, according to the GAO."

"The report -- which was requested by four Democratic lawmakers -- doesn't accuse private insurers of acting improperly when they add as many diagnostic codes as possible; rather, the report says, it has more to do with incentives built into the Medicare program."

"Doctors who treat patients in fee-for-service Medicare get paid based on the medical services they provide. But Medicare Advantage plans have a financial incentive to select as many diagnostic codes per patient that apply, because having patients with a greater number of ailments makes the Medicare Advantage population appear sicker and ultimately brings the plans more money."

"Lawmakers have passed legislation in recent years to adjust risk scores in order to make payments to Medicare Advantage Plans and fee-for-service providers more comparable. A 2005 law required CMS to make risk score adjustments, and in 2010 CMS slightly reduced Medicare Advantage beneficiaries' risk scores, which saved an estimated $2.7 billion for the Medicare program, according to the report. CMS reduced the score again in 2011 and will do the same in 2012."

"Even after the reduction in Medicare Advantage risk scores in 2010, the risk scores were still too high, which accounted for between $1.2 billion and $3.1 billion in overpayments to Medicare Advantage plans, the GAO investigators concluded. The overpayments in 2011 and 2012 will likely be even greater, and CMS needs to update its risk score methodology again or else excess payments will continue to increase, the report said."

 
Post A Comment
* Indicates Required Field
Comment Title:
* Comments:
Nickname:
* Validation:
Most Recent Comments
 
 
FeaturedNews
Clinical Trial Data Should Be Open for Review
Published 04/30/2012 - 3:14 p.m.  CDT

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"
...Read More
HR 329 in need of Co Sponsors
Published 04/30/2012 - 11:11 a.m.  CDT

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.
...Read More
Court Sides with Generic-Drug Makers
Published 04/25/2012 - 6:33 a.m.  CDT

In a unanimous decision, the Supreme Court ruled that generic drugmaker Caraco Pharmaceutical Laboratories can sue Novo Nordisk for what Caraco says are exaggerated descriptions of the scope of patents Novo Nordisk holds on a diabetes drug.

A group of Democratic senators has introduced a bill that would allow people to sue generic drugmakers over failing to update their drug labels to include all known risks. The bill is meant to counter last year's Supreme Court decision in a generic drug dispute.
...Read More
Reader Login
Username:
Password:
 Save Login?
Free Sign-up
Forgot Password?
Reader Control Panel

The TCA Web sites will be under going change in the next few weeks.  Please bear with us while we complete some improvements.

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"

The Kilgore College Small Business Development Center (SBDC) will sponsor an educational seminar for medical office staff, including office managers and billing staff, entitled Basic Workers’ Compensation for Medical Office Staff on Wednesday, May 2, 2012.

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.

An $8 billion Medicare demonstration program is poorly designed and should be cancelled, the nonpartisan Government Accountability Office (GAO) said. The program is designed to reward the highest-quality Medicare Advantage plans, but instead pays out most of its award money to mediocre plans, according to a report.


Ethiopia and Kenya Trips.  Have you ever wanted to provide chiropractic care in another country and give back to those in need?

Dr. Teresa Jones has been volunteering on mission trips to Africa for 4 years and is reaching out to the District 5 for help this year. There are two chances to participate, both in July 2012 and if you are interested please RSVP to frontdesk@wholehealth-care.com to let her know you area interested!


The Patient-Centered Outcomes Research Initiative (PCORI), established by the 2010 Patient Protection and Affordable Care Act, has set five priorities as the group's research agenda for the coming years, with the overall goal of advancing clinical effectiveness research. …. the priorities [are] as follows...

Girls who face multiple social stressors at home as toddlers are more likely to be obese by age 5, researchers found.

Nonpharmacologic pain management appears to be safe for mother and baby, although there is limited published evidence to explain its efficacy, according to a Cochrane Review.

There is more data to support the ef?cacy of pharmacologic pain management, such as epidurals and opioids, but these methods lead to more adverse effects.  This reports reports upon some of these
Regulators on both sides of the Atlantic were slow to inform patients and their doctors about problems with metal-on-metal hip implants and relied on industry officials and consultants in crafting their responses.

Complications included high failure rates and possible systemic effects from elevated metal ion levels in the blood.  An advisory has been issued to surgeons, telling them that patients who have received metal-on-metal implants should have annual checkups for life. The evaluations should include testing for metal ions in the blood as well as for clinical symptoms of device failure.